Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 27;28(5):2234.
doi: 10.3390/molecules28052234.

Recent Advances in Asymmetric Synthesis of Pyrrolidine-Based Organocatalysts and Their Application: A 15-Year Update

Affiliations
Review

Recent Advances in Asymmetric Synthesis of Pyrrolidine-Based Organocatalysts and Their Application: A 15-Year Update

Arianna Quintavalla et al. Molecules. .

Abstract

In 1971, chemists from Hoffmann-La Roche and Schering AG independently discovered a new asymmetric intramolecular aldol reaction catalyzed by the natural amino acid proline, a transformation now known as the Hajos-Parrish-Eder-Sauer-Wiechert reaction. These remarkable results remained forgotten until List and Barbas reported in 2000 that L-proline was also able to catalyze intermolecular aldol reactions with non-negligible enantioselectivities. In the same year, MacMillan reported on asymmetric Diels-Alder cycloadditions which were efficiently catalyzed by imidazolidinones deriving from natural amino acids. These two seminal reports marked the birth of modern asymmetric organocatalysis. A further important breakthrough in this field happened in 2005, when Jørgensen and Hayashi independently proposed the use of diarylprolinol silyl ethers for the asymmetric functionalization of aldehydes. During the last 20 years, asymmetric organocatalysis has emerged as a very powerful tool for the facile construction of complex molecular architectures. Along the way, a deeper knowledge of organocatalytic reaction mechanisms has been acquired, allowing for the fine-tuning of the structures of privileged catalysts or proposing completely new molecular entities that are able to efficiently catalyze these transformations. This review highlights the most recent advances in the asymmetric synthesis of organocatalysts deriving from or related to proline, starting from 2008.

Keywords: asymmetric organocatalysis; proline; substituted pyrrolidines; synthetic methods.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(a) Structures of the progenitors and most-commonly used organocatalysts; (b)–(e) the fundamental stereoselective activation mode of pyrrolidine-based organocatalysts.
Scheme 1
Scheme 1
Use of the ester-containing proline aryl sulfonamide 1 in the conjugate addition of disubstituited aldehydes to acyclic ketones.
Figure 2
Figure 2
Fully substituted prolinamide organocatalysts 2 and 3 and the proposed transition state for the Michael addition of aldehydes to nitrostyrenes.
Scheme 2
Scheme 2
(a) Synthesis of 4-hydroxyprolinamides 4a,b and 5a,b. Reagents and conditions: (a) (i) LiHMDS, THF, −20 °C; 1.5 h; (ii) CH3I, THF, 18 h, −20 °C to rt; I-1a: 48%, I-1b: 26%; (b) NaOH in MeOH/H2O (1:1), reflux, 5 h; I-2: 48%, I-4′: 76%, (c) for I-3a and I-5a: (S)-1-Phenylethylamine, HATU, DIPEA, DMF, rt, 4 h; I-3a: 42%, I-5a: 50%; for I-3b and I-5b: (S)-N,α-dimethylbenzylamine HATU, DIPEA, DMF, rt, 4 h; I-3b: 33%, I-5b: 31%; (d) TBAF (1M), THF, 0° C, 5 h; I-3a’: 92%, I-3b’: 98%, I-4: quantitative (e) 50% TFA/DCM, rt, 16 h., 4a: 28%, 4b: 23%, 4c: 27%, 4d: 24%. (b) Other hydroxyprolinamide catalysts obtained by Kelleher and co-workers.
Figure 3
Figure 3
Prolinamide organocatalysts 7a,b and the proposed transition state for the organocatalytic Michael addition of aldehydes to nitrostyrene.
Scheme 3
Scheme 3
Synthesis of trifluoromethanesulfonamide-substituted prolinamides 8a–d. Reagents and conditions: (a) NHBn2, NaBH(OAc)3, 1,2-DCE, rt, 16 h; (b) (i) H2 (1 atm), Pd/C, MeOH, rt, 24 h; (ii) Tf2O, Et3N, DMAP, DCM, 0 °C to rt, 1 h; (c) TFA, DCM, 0 °C to rt, 6 h; (d) EDC HCl, HOBt, DIPEA, DCM, 0 °C to rt.
Figure 4
Figure 4
Prolinamides 9a–d.
Figure 5
Figure 5
Bifunctional prolinamide catalysts 10a,b and the corresponding transition states.
Scheme 4
Scheme 4
(a) Synthesis of prolinamides organocatalyst 11, 12, and 13a,b. Reagents and conditions: (a) ClCO2Et, Et3N, DCM, 0 °C to rt; (b) (i) Camphorsulfonyl chloride, Et3N, DCM, 0 °C. 1 h; (ii) TFA, DCM, 0 °C, 1 h, 65%; (c) (i) Ketopinic chloride, Et3N, DCM, 0 °C. 1 h; (ii) TFA, DCM, 0 °C, 1 h, 65%; (d) For 13a: (i) thiocyanatobenzene, DCM, 0 °C to rt; (ii) TFA, DCM, 0 °C, 1 h, 60%; For 13b: (i) 1-thiocyanato-3,5-bis(trifluoromethyl)benzene, DCM, 0 °C to rt; (ii) TFA, DCM, 0 °C, 1 h, 64%. (b) Synthesis of prolinamides organocatalyst 14a–c. Reagents and conditions: (e) (i) SOCl2, reflux; (ii) NH4SCN, acetone; (iii) o-phenylenediamine; (f) For 14a: N-Boc-L-Proline, ethylchloroformiate; for 14b,c: N-Boc-4-hydroxy-L-Proline, ethylchloroformiate; (g) Only for 14c: TBDPSCl, DMAP, DCM; (h) TFA, DCM. (c) Synthesis of prolinamides organocatalyst 15a,b. Reagents and conditions: (i) (i) RCH2Br, NaH, THF, 0 °C; (ii) TFA, DCM; 15a: 61%, 15b: 45%.
Figure 6
Figure 6
Series of prolinamide-based organocatalysts characterized by different carbocyclic rings or variably substituted aromatics.
Scheme 5
Scheme 5
(a) Synthesis of prolinamide-organocatalysts 7b,c, 18a-h, 20 applied in the organocatalytic Biginelli reaction. (b) Synthesis of prolinamide-organocatalysts 18i,j applied in the same Biginelli reaction.
Figure 7
Figure 7
Bifunctional prolinamide-based organocatalysts 21a–d.
Scheme 6
Scheme 6
Series of prolinamide-organocatalysts employed in the reaction of isatin with acetone (Py = pyridine, Qn = quinoline).
Scheme 7
Scheme 7
Series of prolinamide-organocatalysts employed in the enantioselective cross-aldol reaction between acetone and trihalomethyl ketones or imines.
Scheme 8
Scheme 8
(a) Synthesis of organocatalysts 25a–d. Reagents and conditions: (a) LiAlH4, THF, 0 °C to rt, 81–98%; (b) (i) NaH, THF, rt; (ii) TBDMSCl, 85–89%; (c) TsCl, pyr, DMAP, 0 °C to rt, 80–85%; (d) NaN3, DMF, 70 °C, 99%; (e) H2 (50 psi), Pd/C, AcOEt/EtOH, 88–90%; (f) L-Pro-Cbz, HOBt, EDC, Et3N, DCM, 0 °C to r.t, 88–90%; (g) TBAF, THF, rt, 85–97%; (h) H2 (50 psi), Pd/C, MeOH, 25a: 91%, 25b: 87% , 25c:97%, 25d: 87%;(i) BAIB/Tempo, DCM/H2O, 84–97%. (b) Synthesis of organocatalysts 25e. Reagents and conditions: (a) (i) LDA, THF, −78 °C; (ii) MeOH, 98%; (b) Ti(OiPr)4, iPrOH, 10 °C, 10 days, 82%; (c) LiAlH4, THF, 70 °C 96%; (d) (i) NaH, THF, rt; (ii) TBDMSCl, 60%; (e) NH3, DIAD, PPh3, THF, 0 °C, 84%; (f) H2 (50 psi), Pd/C, AcOEt/EtOH, 99%; (g) L-Pro-Cbz, HOBt, EDC, Et3N, DCM, 0 °C to r.t, 81%; (g) TBAF, THF, rt, 98%; (h) H2 (50 psi), Pd/C, MeOH, 99%. (c) Synthesis of organocatalysts 25f. Reagents and conditions: (a) (i) LDA, THF, 97%; (b) TsCl, pyr, DMAP, 0 °C to rt, 95%; (c) NaN3, DMF, 70 °C, 93%; (d) H2 (50 psi), Pd/C, AcOEt/EtOH, 99%; (e) L-Pro-Cbz, HOBt, EDC, Et3N, DCM, 0 °C to r.t, 93%; (f) H2 (50 psi), Pd/C, MeOH, 99%. (d) Synthesis of organocatalysts 26g. Reagents and conditions: (c) TsCl, pyr, DMAP, 0 °C to rt, 87%; (d) NaN3, DMF, 70 °C, 90%; (e) H2 (50 psi), Pd/C, AcOEt/EtOH, 99%; (f) L-Pro-Cbz, HOBt, EDC, Et3N, DCM, 0 °C to r.t, 83%; (h) H2 (50 psi), Pd/C, MeOH, 99%.
Figure 8
Figure 8
N-prolyl sulfinamide-catalysts 27a–d containing two stereogenic centers.
Figure 9
Figure 9
Phthalimido-prolinamide catalyst 28 and its transition state in the enantioselective direct aldol reaction of aromatic aldehydes with ketones.
Figure 10
Figure 10
AZT-Prolinamides 29a,b employed in the enantioselective direct aldol reaction.
Figure 11
Figure 11
Intermolecular hydrogen bonding network in the transition state involving catalysts 6c,d.
Figure 12
Figure 12
Homochiral L-prolinamido-sulfonamides 30a–h and their calculated transition state for the asymmetric aldol reaction between acetone and aromatic aldehydes.
Figure 13
Figure 13
Peptides 31b–g structurally related to organocatalyst 31a.
Figure 14
Figure 14
Tripeptides 32a–f employed to catalyze the asymmetric aldol reaction.
Scheme 9
Scheme 9
Tripeptide 33 employed in the asymmetric aldol reaction between acetone and α-ketoesters or α-keto amides.
Scheme 10
Scheme 10
Synthesis of dipeptide organocatalyst 34. Reagents and conditions: (a) CbzCl, NaOH, 0 °C, 2 h, 93%; (b) O-Bn-L-threonine, EDC, HOBt, DCM:DMF (4:1), rt, 14 h, 92%; (c) TBSCl, imidazole, DCM:DMF (10:1), rt, 24 h, 78%; (d) Pd(OH)2/C, H2 (1 atm), rt, 12 h, 74%.
Figure 15
Figure 15
Prolinamide catalysts 35a–c, resembling dipeptides.
Figure 16
Figure 16
Series of dipeptide-like organocatalysts 36a–h, employed in the asymmetric aldol reaction in brine.
Figure 17
Figure 17
Proline-based α,β-dipeptides 37a–c.
Figure 18
Figure 18
Proline-based dipeptides 38a–e as organocatalysts for the asymmetric aldol reaction both in organic and aqueous media.
Figure 19
Figure 19
Hybrids dipeptide-2-pyrrolidone organocatalysts 39a–f.
Figure 20
Figure 20
(a) Pseudotripeptide catalysts 40a–m, characterized by the anthranilamide moiety. (b) Binding pocket characteristic of this type of catalysts. (c) Intramolecular hydrogen bonding.
Scheme 11
Scheme 11
Tripeptide-like catalyst 41 employed for asymmetric aldol reaction between ketones and perfluoroalkyl ketones.
Figure 21
Figure 21
Proline-based di- and tri-peptides 42a–d employed in the asymmetric Michael reaction between ketones and nitroolefins “on water.”
Figure 22
Figure 22
Tripeptide H-D-Pro-Pro-Glu-NH2 43a.
Figure 23
Figure 23
(a) Amide bond conformations of H-Pro-Pro-Xaa-NH2-type peptide organocatalysts. (b) Examples of the studied catalysts.
Scheme 12
Scheme 12
(a) Conjugate addition reaction of aldehydes to α,β-disubstituted nitroolefins. (b) General structure of the evaluated organocatalysts (43c).
Scheme 13
Scheme 13
Asymmetric conjugate addition of aldehydes to β,β-disubstituted nitroalkenes.
Figure 24
Figure 24
Series of bifunctional L-prolinamides organocatalysts 44a–d resembling dipeptides.
Scheme 14
Scheme 14
(a) Synthesis of bifunctional tripeptides carrying phosphonic acid. Reagents and conditions: (a) Boc2O, Na2CO3, NaHCO3 (satd), rt, 24 h, >99%; (b) (i) DEAD, Ph3P, THF, −78 °C; (ii) 2-((tert-butoxycarbonyl)amino)-3-hydroxypropanoic acid, THF, −78 °C to rt 2.5 h; (c) P(OMe)3, 70 °C, 24 h, 53% over two steps; (d) TFA, DCM, rt, 4 h, 74%; (e) LDA, tetraethyl methylenebis(phosphonate), −78 °C, 1 h, rt, 3 h, 98%, Z/E 60/40; (f) H2 (1 atm), Pd/C, EtOH, rt, 2 h; (g) PTSA, MeOH, rt, 6 h, 85% over two steps; (h) BAIB, TEMPO, NaHCO3, 0 °C, 2 h, 90%; (i) TFA, rt, 4 h; (j) AcCl, MeOH, reflux, 2 h, >99% over two steps; (k) EDC∙HCl, HOBt, Et3N, DCM, 0 °C, 30 min, rt, 12 h, 40–60%; (l) (i) TMSBr, CH3CN, −10 °C to rt, 4 h; (ii) MeOH, 1 h, rt; (iii) NaOH; H2O then lyophilization, 95%. (b) Key functional groups of these tripeptides. (c) Series of synthesized phosphonic acid-containing tripeptides 45a–h.
Figure 25
Figure 25
Series of new hybrid dipeptide-like organocatalysts 46a–m.
Scheme 15
Scheme 15
(a) Anti-selective conjugate addition between aldehydes and nitroolefins promoted by organocatalyst 43e (Curtin–Hammett scenario). (b) Best-performing catalyst, 43e.
Scheme 16
Scheme 16
(a) Synthesis of the tricyclic chiral catalyst 47a. Reagents and conditions: (a) DCC, BnOH, DCM, 0 °C to rt, 2 h, 98%; (b) TFA, 32 h, rt, 88%; (c) ethylchloroformate, Na2CO3, 0 °C to rt, 12 h, 86%; (d) H2 (1 atm), Pd/C, MeOH, rt, 12 h, 100%. (b) Calculated transition state. (c) Other tricyclic chiral catalyst 47b,c.
Scheme 17
Scheme 17
(a) Synthesis of the cis-ion-tagged organocatalyst 48a. Reagents and conditions: (a) 2-chloroacetyl chloride, DCM, −20 °C, 3 h, 86%; (b) N-Me-Imidazole, MeCN, 16 h, 50 °C, 65%; (c) LiNTf2, DCM, rt, 12 h, 92%.; (d) H2 (1 atm), Pd/C, MeOH, rt,12 h, 96%. (b) Ion-tagged cis-ester 48b. (c) Calculated transition state for catalyst 48a.
Scheme 18
Scheme 18
Synthesis of organocatalyst 49. Reagents and conditions: (a) oxalyl chloride, DMF, benzene, rt, 12 h, 95%, (b) 4-hydroxy-L-proline, TFA, CF3SO3H, rt, 3 h, 87%, (c) Et3N, EtOAc, rt, 90%.
Scheme 19
Scheme 19
Synthesis of pyridinium-pyrrolidines 50a–d. Reagents and conditions: (a) Zincke salt, nBuOH, reflux, 35 h, 82%; (b) (i) 4 M HCl/dioxane, rt, 5 h; (ii) solid NaHCO3, 98%; (c) 50b: AgBF4, CH3CN, 92%; 50c: KPF6, H2O, 1 h, 94%; 50d: LiNTf2, H2O, 1 h, 98%.
Scheme 20
Scheme 20
Synthesis of thio-pyrrolidines 51a–c. Reagents and conditions: (a) NaBH4, I2, THF, rt, 5 h, reflux, 20 h, 88%; (b) (i) 20% HBr/H2O; (ii) EtOH, PBr3, reflux, 10 min, 86%; (c) substituted mercapto-imidazole, CH3CN, 80 °C, 8 h, yields not reported.
Scheme 21
Scheme 21
Synthesis of ionic liquid anchored triazole-pyrrolidines 52a–c. Reagents and conditions: (a) BH3∙SMe2, THF, 0 °C, 5 h, rt, overnight, 95%; (b) TsCl, pyridine, rt, 6 h, 84%; (c) NaN3, DMSO, 64 °C, 19 h, 90%; (d) propargyl chloride, toluene, reflux, 8 h, >99% [91]; (e) CuI, DIPEA, EtOH, reflux, 24 h; (f) 5 M HCl, EtOH, 52a: 73%; (g) 52b: NaBF4, CH3CN/acetone (4:1), rt, 2 days, 95%; 52c: KPF6, CH3CN/acetone (4:1), rt, 2 days, 92%.
Scheme 22
Scheme 22
Synthesis of ionic liquid anchored sulfonamido-pyrrolidines 53a,b. Reagents and conditions: (a) chlorosulfonyl chloride, Et3N, DCM, 0 °C to rt, 17 h, a: 72%, b: 98%; (b) a: (i) NaI, acetone, rt, 24 h, 96%; (ii) 1-methyl-imidazole, CH3CN, 65 °C, 14 h, 90%; b: 1-methyl-imidazole, toluene, reflux, 3 days, 75%; (c) (i) TFA/DCM (1:1), rt, 2 h; (ii) NaHCO3, LiNTf2, 1 h, rt, 55a: 88%, 53b: 90% over two steps.
Scheme 23
Scheme 23
Synthesis of ionic liquid anchored sulfonamido-pyrrolidine 54. Reagents and conditions: (a) 1-methyl-2sufonylchlorideimidazole, Et3N, DCM, 0 °C to rt, 1 h, 96%; (b) Me3OBF4, AcOEt, 0 °C to rt, 2 h, 90%; (c) 4 M HCl/dioxane, rt, 5 h, 95%.
Scheme 24
Scheme 24
Synthesis of bifunctional pyrrolidines 55a,b. Reagents and conditions: (a) benzyl (2-aminoethyl)carbamate (n = 1, HCl salt) or benzyl (3-aminopropyl)carbamate (n = 2, TFA salt), EDC, HOBt, iPr2NEt, DMF/THF, 0 °C to rt, 17 h, 79% (n = 1), 71% (n = 2); (b) BH3∙THF, THF, 0 °C to rt, 7 days, 69% (n = 1), 60% (n = 2); (c) Pd/C (10 mol%), H2 (1 atm), MeOH, rt, 5 h, 98%; (d) PhNCS, CHCl3, MeOH, aq NaHCO3, rt, 3 h, 68% (n = 1), 47% (n = 2); (e) 10% v/v TFA/DCM, rt, then aq K2CO3, rt, 30 min 88% (n = 1), >99% (n = 2).
Scheme 25
Scheme 25
Synthesis of phosphine oxide substituted pyrrolidine 56. Reagents and conditions: (a) TsCl, pyridine, 0 °C, 4 h, 92%; (b) (i) Na, ClPPh2, dioxane, reflux, 15 h; (ii) (S)-N-tButoxycarbonylprolinol p-toluenesulfonate, rt, 19 h, 93%; (c) 30% H2O2, DCM, rt, 30 min; (d) TFA, DCM, rt, 12 h, 92% over two steps.
Scheme 26
Scheme 26
Synthesis of pyrrolidinyl–camphor catalysts 57a,b. Reagents and conditions: (a) BH3∙THF, 0 °C, 1 h, 96%; (b) pyridine, DCM, 40 °C, TsCl (syringe pump, 10 h), 8 h, 69%; (c) PCl5, 0 °C to rt, 1 h, 96%; (d) Ph3P, H2O/dioxane (1:4), reflux, 1 h, 82%; (e) NaH, THF, rt, 2 h, 88%; (f) NaBH4, DCM/MeOH (1:1), rt, 2 h; (g) TFA, DCM, rt, 1–3 h, 57a: 60%, 57b: 82% over two steps.
Scheme 27
Scheme 27
Synthesis of pyrrolidinyl–camphor catalyst 58. Reagents and conditions: (a) PCl5, 0 °C to rt, 1 h, 96%; (b) Na2CO3, KMnO4, H2O, heat, 1 h, 40%; (c) (i) ethyl chloroformate, Et3N, acetone/H2O, NaN3, 0 °C to rt; (ii) 0.08 N HCl, 80 °C, 75%; (d) DIBAL-H, toluene, −78 °C, 2 h, 90%; (e) Ti(iPrO)4, THF, rt, 12 h; (f) NaBH4, EtOH, rt, 12 h, 52% over two steps; (g) TFA, DCM, rt, 19 h, 79%.
Scheme 28
Scheme 28
Synthesis of pyrrolidine-pyridine-based catalysts 59ad. Reagents and conditions: (a) (i) NaH, THF, 0 °C to rt, 12 h; (ii) 2-bromopyridine, reflux, 24 h, 71%; (b) TFA, DCM, 0 °C to rt, 12 h, 92%.
Scheme 29
Scheme 29
Synthesis of 4-trifluoromethanesulfonamidyl prolinol tert-butyldiphenylsilyl ether 60. Reagents and conditions: (a) SOCl2, MeOH, 0 °C to 40 °C, 2 h; (b) Boc2O, Na2CO3, THF/H2O (3:1), 0 °C to rt, 12 h; (c) PhCOOH, Ph3P, DIAD, THF, 0 °C to rt, 12 h; (d) LiOH∙H2O, THF/MeOH/H2O (1:1:1), 0 °C to rt, 12 h; (e) Me2SO4, K2CO3, acetone, 0 °C to rt, 12 h, 81% over five steps; (f) MsCl, Et3N, DCM, 0 °C to rt, 12 h, 97%; (g) NaBH4, THF/MeOH, 0 °C to rt, 12 h, 99%; (h) TBDPSCl, imidazole, DCM, 0 °C to rt, 12 h, 95%; (i) NaN3, DMF, 70 °C, 12 h, 86%; (j) (i) Ph3P, THF, rt, 4 h; (ii) H2O, 80 °C, 12 h, 81%; (k) Tf2O, DIPEA, DCM, −78 °C to rt, 12 h, 70%; (l) TFA, DCM, 0 °C, 6 h, 76%.
Scheme 30
Scheme 30
Synthesis of binaphthyl sulfonimide pyrrolidine 61. Reagents and conditions: (a) (i) NaH, DMF, 0 °C, 2 h; (ii) N,N-dimethylthiocarbamoyl chloride, 85 °C, 4 h, 69%; (b) MW (300 W), 200 °C, 20 min, 65%; (c) N-chlorosuccinimide, 2 M HCl/CH3CN, 0 °C to 10–20 °C, 30 min; 87%; (d) DCM, Et3N, rt, 12 h; (e) TFA, DCM, rt, 4 h, 41% over two steps.
Scheme 31
Scheme 31
Synthesis of sugar-based pyrrolidine 62. Reagents and conditions: (a) (i) Ph3P, I2, imidazole, DCM, rt, 2 h; (ii) NaN3, DMF, rt, 5 h, 67% over two steps; (c) diacetone-D-glucose, NaH, THF, rt to 70 °C, 2 h, 76%; (d) CuI (20 mol%), DIPEA, CHCl3/EtOH/H2O (9:1:1), rt, 16 h; (e) DMF/piperidine, rt, 30 min, 78% over two steps.
Scheme 32
Scheme 32
Synthesis of aminophosphonic acid monoester pyrrolidine 63. Reagents and conditions: (a) LiAlH4, THF, reflux, 2 h, >99%; (b) CbzCl, Et3N, DCM, rt, 18 h, 63%; (c) MsCl, Et3N, DCM, 0 °C to rt, 3 h; (d) NaI, acetone, reflux, 12 h; (e) (EtO)2P(O)H, NaH, DMF, 55 °C, 5 days, 76% over three steps; (f) LiBr, CH3CN, reflux, 15 h; (g) 0.6 M HCl, rt, 30 min; (h) H2 (1 atm), Pd(OAc)2 (20 mol%), EtOH, rt, 4 days, 88% over three steps.
Scheme 33
Scheme 33
Synthesis of sulfone pyrrolidine 64. Reagents and conditions: (a) Et3N, (Boc)2O, DCM, 0 °C, 2.5 h, 94%; (b) BH3∙THF, THF, 0 °C, 2 h, rt, 1 h, 82%; (c) TsCl, pyridine, 0 °C, 4 h, 92%; (d) (i) 2-naphthalenethiol, NaH, THF, 0 °C, 5 min; (ii) O-tosyl-pyrrolidinol, reflux, 5 h, 76%; (e) mCPBA, DCM, rt, 2.5 h, 90%; (f) TFA, DCM, rt, 5 h, 90%.
Scheme 34
Scheme 34
Synthesis of thiourea-amine bifunctional organocatalyst 65. Reagents and conditions: (a) CS2, DCC, Et2O, 0 °C to rt, 3 h, rt 12 h, 76%; (b) Ph3P, HN3/benzene, DIAD, THF, 5 °C to rt, 3 h; (c) (i) Ph3P, THF, 40 °C; (ii) H2O, rt, 3 h, 61% over two steps; (d) DCM, rt, 9 h, 88%; (e) DCM, TFA, 12 h, rt, 55%.
Scheme 35
Scheme 35
Synthesis of bifunctional 2-amino-pyridine pyrrolidine organocatalyst 66. Reagents and conditions: (a) CbzCl, NaOH, 0 °C, 4 h, 87%; (b) SOCl2, reflux, 2 h, 99%; (c) 2-aminopyridine, Et3N, DCM, 0 °C, 12 h, 74%; (d) H2 (1 atm), Pd/C (10%, w/w), CH3OH, 24 h, 92%; (e) LiAlH4, THF, rt, 24 h, 74%.
Scheme 36
Scheme 36
Synthesis of 1H-benzo[d]imidazole-pyrrolidine bifunctional organocatalyst 67. Reagents and conditions: (a) BnBr, Et3N, DCM, 8 h, 99%; (b) LiAlH4, THF, 0 °C to rt, 20 h, 97%; (c) (i) Ph3P, phtalimide, THF, 10 min; (ii) DEAD, reflux, 8 h; (d) (i) hydrazine monohydrate, EtOH, reflux 2 h; (ii) HCl 1M, reflux 30 min, 70% over two steps; (e) HCl, urea, 130–140 °C, 6 h, 90%; (f) phosphoryl chloride, reflux, 2 h, 45%; (g) Et3N, 190–200 °C, 16 h; (h) H2 (1 atm), Pd/C (10 mol%), CH3OH, rt, 48 h, 41% over two steps.
Scheme 37
Scheme 37
(a) Synthesis of pyrrolidine (thio)ureas 68a–e. Reagents and conditions: (a) MeOH, SOCl2, Et3N, 0 °C to 40 °C, 2 h; (b) Boc2O, Na2CO3, THF/H2O (3:1), 0 °C to rt (c) PhCOOH, Ph3P, DIAD, THF. 0 °C to rt; (d) LiOH, THF/MeOH/H2O (1:1:1), 0 °C to rt; (e) Me2SO4, K2CO3, acetone, 0 °C, 81%; (f) MsCl, Et3N, DCM, 0 °C to rt, 97% (g) NaBH4, THF, MeOH, 0 °C to rt, 99%, (h) TBDPSCl, imidazole, DCM, 0 °C to rt, 95% (i) NaN3, DCM, rt, 86% (j) (i) Ph3P, THF, rt; (ii) H2O, 80 °C, 81%; (k) RNCS, rt; (l) TFA, DCM, 0 °C to RT, 6 h. 40–45% over two steps. (b) All the catalysts synthetized with a similar procedure. (c) Proposed transition state.
Scheme 38
Scheme 38
Synthesis of fluorous (S)-pyrrolidine–thiourea bifunctional organocatalyst 69. Reagents and conditions: (a) DIPEA, pyridine, DCM, 58%; (b) TFA, DCM, 95%.
Scheme 39
Scheme 39
(a) Synthesis of organocatalysts 70a and 71a–d. Reagents and conditions: (a) CSCl2, DCM, aq. NaHCO3; (b) tert-butyl (S)-2-(aminomethyl)pyrrolidine-1-carboxylate, DCM; (c) 6 N HCl/MeOH, AcOH, 100 °C, 3 h, 70a: 88%, 71a: 76%, 71b: 72%, 71c: 80%, 71d: 85%. (b) Transition state for catalyst 70a.
Scheme 40
Scheme 40
Synthesis of pyrrolidinyl-sulfamide organocatalysts 72a–d and 73a–d. Reagents and conditions: (a) Et3N, DCM, 0 °C; (b) tert-butyl (S)-2-(aminomethyl)pyrrolidine-1-carboxylate, DCE, reflux; (c) TFA, DCM, 0° C to rt; (d) tert-butyl (S)-2-(aminomethyl)pyrrolidine-1-carboxylate, Et3N, DCM, 0 °C; (e) DCE, reflux.
Figure 26
Figure 26
Organocatalysts composed of the polyoxometalate acid and chiral diamines 74a–e.
Scheme 41
Scheme 41
(a) Simultaneous dual activation of aldehydes and nitroolefins obtained employing catalyst type 75. (b) Synthesis of squaramide-based aminocatalysts 75a,b. (c) Asymmetric Diels–Alder reaction of anthracenes using nitroalkenes as dienophiles.
Scheme 42
Scheme 42
Synthesis of organocatalysts 76 and 77. Reagents and conditions: (a) Boc2O, 83%; (b) ClCO2C2H5, Et3N, DCM then (R)-α-methylbenzyl amine, 85%; (c) HCOOH, 80%; (d) LiAlH4, 70%.
Scheme 43
Scheme 43
Synthesis of organocatalysts 78a–d.
Scheme 44
Scheme 44
Synthesis of organocatalyst 79. Reagents and conditions: (a) Me2S BH3, THF, 0 °C to rt, 92%; (b) TsCl, pyridine, 0 °C, 91%; (c) NaH, THF, 0 °C; PhSH, reflux, 5 h, 83%; (d) NaIO4, MeOH/H2O, 0 °C to rt, 92%; (e) TFA, DCM, 5 h, rt, 89%.
Scheme 45
Scheme 45
Synthesis of organocatalyst 80a,b. Reagents and conditions: (a) THF, reflux, 23 h, 80a: 98%, 80b: 84%; (b) For 80a: tert-butyl (R)-2-(aminomethyl)pyrrolidine-1-carboxylate, THF, reflux, 20 h; for 80b: tert-butyl (R)-2-(aminomethyl)pyrrolidine-1-carboxylate, THF, reflux, 50 h, 89%; (c) For 80a: TFA, DCM, rt, 30 min, 34% over the two steps; For 80b: TFA, DCM, rt, 3 h, 75%.
Scheme 46
Scheme 46
Synthesis of organocatalyst 81 and proposed stereochemical model for the Michael addition of ketones to nitroolefins. Reagents and conditions: (a) (i) SOCl2, MeOH, rt to 45 °C, 6 h; (ii) Boc2O, rt, 16 h, 95% over the two steps; (b) DAST, DCM, −78 °C, 16 h, 78%; (c) DIBAL-H, DCM, −78 °C, 6 h, 68%; (d) pyrrolidine, NaBH3CN, 4Å MS, MeOH, 0 °C, 12 h, 54%; (e) (i) HCl/Et2O, rt, overnight; (ii) 1M NaOH, rt, 2 h, 90% over two steps.
Scheme 47
Scheme 47
Synthesis of organocatalysts 70b–d. Reagents and conditions: (a) (i) MsCl, Et3N, DCM; (ii) PhCOONa, DCM, 90 °C; (iii) K2CO3, MeOH; (b) TBDMSCl, imidazole, DCM, rt; 82–88%; (c) DAST, DCM, −78 °C, 67–77%; (d) DIBAL-H, DCM, −78 °C, 51–61%; (e) MsCl, Et3N, DCM; (f) NaN3, DMF; 47–73% over two steps; (g) (i) PPh3, THF 65 °C; (ii) H2O, 65 °C; (h) methyl (S)-3-isothiocyanato-3-phenylpropanoate, 46–71% over two steps; (h) HCl 6 N/MeOH, AcOH; 70b: 64%, 70c: 92%, 70d: 44%, 70e: 55%.
Scheme 48
Scheme 48
Synthesis of organocatalysts 82a,b. Reagents and conditions: (a) EDC, HOBt, DCM, rt, 8 h, I-25a: 81%, I-25b: 81%; (b) Pd/C, H2 (1 atm), MeOH, rt, 12 h, 82a: 84%, 82b: 82%.
Scheme 49
Scheme 49
Synthesis of organocatalysts 83a,b and transitions states for the Michael addition in water (A) and for the neat conditions in presence of p-nitrobenzoic acid (B). Reagents and conditions: (a) PPh3, DIAD, THF, 0 °C to rt, 4–6 h, I-27a: 93%, I-27b: 90%; (b) TFA, DCM, 0 °C to rt, 3 h, 83a: 91%, 83b: 87%.
Scheme 50
Scheme 50
Synthesis of pyrrolidine-oxytriazole catalyst 84. Reagents and conditions: (a) PPh3, DIAD, THF, 0 °C to rt, 4–6 h, 88%; (b) TFA, DCM, 0 °C to rt, 3 h, 93%.
Scheme 51
Scheme 51
Synthesis biaryl-based organocatalysts 85a–c.
Scheme 52
Scheme 52
Synthesis of perhydroindolinol 89. Reagents and conditions: (a) (i) SOCl2, MeOH, rt; (ii) LiAlH4, THF, rt, 92% over two steps.
Scheme 53
Scheme 53
Synthesis of pyrrolidine sulfinamide 90. Reagents and conditions: (a) (i) NaBH4, THF, 0 °C, 1 h; (ii) BF3∙Et2O, 0 °C, 18 h, 93%; (b) DMSO, oxalyl chloride, Et3N, DCM, −78 °C, 1 h, 0 °C, 30 min; (c) (S)-2-methylpropane-2-sulfinamide, CuSO4, DCM, rt, 48 h, 89% over two steps; (d) NaBH4, THF, 0 °C, 1 h, 86%; (e) Et2NH, THF, rt, 2 h, 52%.
Scheme 54
Scheme 54
Synthesis of (thio)carbamate-derived organocatalysts 91a,b. Reagents and conditions: (a) BH3∙Me2S, THF, 93%; (b) for 91a: isocyanatobenzene, DMAP, DCM, 91%; for 91b: isocyanatobenzene, BF3∙Et2O, THF, reflux, 42%; (c) HCOOC, 91a: 84%, 91b: 81%.
Scheme 55
Scheme 55
Synthesis of organocatalyst 92a,b. Reagents and conditions: (a) for I-28a: LiAlH4, THF, 70 °C, 3 h, 94%; for I-28b: LiBH4, rt, 48 h, 93%; (b) Boc2O, NaHCO3, THF:H2O (1:1), rt, 16 h, 58–98%; (c) TsCl, Et3N, DMAP, DCM, rt, 16 h, 62–95%; (d) NaCN, DMSO, 80 °C, 8 h, 45–68%; (e) 50% NH2OH (aq), EtOH, rt, 48 h; 74–83% (f) 1,1’-Carbonyldiimidazole, THF, 70 °C, 16 h; 37–63% (g) 4 M HCl in dioxane, rt, 4 h, 92a: 97%, 92b: 98%.
Scheme 56
Scheme 56
Synthesis of thiosquaramide organocatalysts 93a–c. Reagents and conditions: (a) cyclopentanol, PhMe, reflux, 8 h, 86%; (b) Lawesson’s reagent, DCM, rt, 48 h, 62%; (c) I-30a–c, DCM, 0 °C to rt, I-30a: 80%, I-30b: not given, I-30c: 83%; (d) tert-butyl (R)-2-(aminomethyl)pyrrolidine-1-carboxylate, DCM, 0 °C to rt, 1.5 h; (e) TFA, DCM, 0 °C to rt, 1.5 h, 93a: 73%, 93b: 51%, 93c: 55% over two steps.
Scheme 57
Scheme 57
Synthesis of N-sulfinylpyrrolidine thioureas and ureas 94a,b and 95a,b. Reagents and conditions: (a) PPh3, DIAD, DPPA, THF, rt; (b) PPh3, 75 °C; (c) H2O, 56% over 3 steps; (d) CSCl2, TEA, THF, rt, 86%; (e) bis(trichloromethyl)carbonate, DIPEA, THF, rt, 100%; (f) nBuLi, THF, 80–90% for thioureas, 24% for ureas; (g) TFA, DCM, 96–98%.
Scheme 58
Scheme 58
Squaramide 75c and thiosquaramide 93a organocatalysts proposed by Kupai and organocatalyzed asymmetric conjugate addition.
Scheme 59
Scheme 59
(a) Synthesis of amidomethylpyrrolidines 96. Reagents and conditions: (a) TsCl, KOH, DCM, rt, 93%; (b) NaN3, DMF, 80 °C, 80%; (c) H2 (1 atm), Pd/C, MeOH, rt, 94%; (d) C6F5SO2Cl, Et3N, DCM, rt, 80%; (e) 3,5-(NO2)2C6H3CH2Br, K2CO3, DMF, rt, 74%; (f) TFA, DCM, rt, 90%. Yields reported for catalyst 96k. (b) Organocatalyzed cascade reaction to anti-α-carbolinol and proposed transition state. (c) Synthesized iodinated organocatalysts.
Scheme 60
Scheme 60
Synthesis of aminal-pyrrolidine organocatalysts 98a–f. Reagents and conditions: (a) BH3∙SMe2, THF, 99%; (b) PCC, DCM, MS (4Å), 74%; (c) diamines, DCM, MS (4Å), K2CO3; (d) H2 (1 atm), Pd/C, AcOEt, 51–82%.
Scheme 61
Scheme 61
Synthesis of (S)-(pyrrolidin-2-yl)diphenyl methyl amine 99. Reagents and conditions: (a) SOCl2, MeOH, 0 °C, 1 h, 100%; (b) BnBr, Et3N, CH2Cl2, 25 °C, 8 h, 95%; (c) bromobenzene, Mg, THF, 25 °C, 12 h, 97%; (d) H2SO4/CHCl3, NaN3, 0 °C, 12 h, 96%; (e) LiAlH4, THF, reflux, 8 h, 95%; (f) H2 (60 psi), Pd/C, MeOH, 25 °C, 99%.
Scheme 62
Scheme 62
Zhong (above) and Lee (below) one-pot synthesis of (S)-2-(azidodiphenylmethyl)pyrrolidine (100), starting from α,α-diphenyl-(S)-prolinol.
Scheme 63
Scheme 63
Synthesis of 2-tritylpyrrolidine 101. Reagents and conditions: (a) trityllithium, −78 °C to rt, 2 h, 54%; (b) H2 (1 atm), Pd/C, AcOH, 25 °C, 12 h, 98%; (c) (i) (S)-malic acid; H2O/EtOH, (ii) 1N NaOH, 30%.
Scheme 64
Scheme 64
Synthesis of silylated perhydroindolinylmethanol catalyst 102. Reagents and conditions: (a) ClCOOEt, K2CO3, MeOH, rt, 98%; (b) PhMgBr, Et2O, 0 °C, 91%; (c) KOH, MeOH, 80 °C, 91%; (d) TMSCl, Et3N, DCM, 0 °C to rt, 84%.
Scheme 65
Scheme 65
Synthesis of di(methylimidazole)prolinol silyl ethers 103a,b. Reagents and conditions: (a) (i) 1-methyl-1H-imidazole, BuLi, THF, −78 °C to rt, 1 h; (ii) N-Boc-L-proline methyl ester, THF, −78 °C to rt, 12 h, 53%; (b) TFA, DCM, rt, 3 h, 82%; (c) TMSOTf or TESOTf, Et3N, DCM, 0 °C to rt, 2 h, 103a: 80%, 103b: 74%.
Scheme 66
Scheme 66
Synthesis of ionic-tagged silylated α,α-diphenyl-(S)-prolinol 104. Reagents and conditions: (a) 3-chloropropyl-dimethylchlorosilane, imidazole, DMF, 25 °C, 12 h, 81%; (b) 1-methyl-imidazole, 80 °C, 12 h, 94%; (c) LiNTf2, H2O/DCM, 25 °C, 2 h, 94%; (d) H2 (1 atm), Pd/C, MeOH, 25 °C, 12 h, 90%.
Scheme 67
Scheme 67
Synthesis of aminal-pyrrolidine organocatalysts 105a,b. Reagents and conditions: (a) SOCl2, MeOH, 97%; (b) PPh3, DEAD, phenol, DCM, 63%; (c) (i) DIBAL-H, toluene; (ii) diamine, DCM, MS (4 Å), K2CO3; (d) H2 (1 atm), Pd/C, AcOEt, 39–42%, over two steps.
Scheme 68
Scheme 68
Synthesis of 2-silylated pyrrolidines 106. (A) Reagents and conditions: (a) (i) sec-BuLi/(−)sparteine, Et2O, −78 °C, 4 h; (ii) R3SiCl, −78 °C to rt, 12 h, 66–93%; (b) HCl/Et2O, HCl (conc.), rt, 12 h, 18–90%. (B) Reagents and conditions: (a) (i) sec-BuLi/(−)sparteine, Et2O, −78 °C, 4 h; (ii) Ph2Si(OMe)2, −78 °C to rt, 12 h; (b) (i) PhLi, Et2O, −78 °C to 0 °C, 3 h, 50% overall yield; (c) AcCl/EtOH, AcOEt, rt, 12 h, 70%.
Scheme 69
Scheme 69
Synthesis of 2-silylated pyrrolidines 106 using fluorosilanes. Reagents and conditions: (a) (i) sec-BuLi/(−)sparteine, Et2O, −78 °C, 5.5 h; (ii) Ph2RSiF, −78 °C to rt, 30 min, 90–93%; (b) (i) ZnBr2, DCM, 15 h, 85–86%; (ii) enantioenrichment (recrystallization from 99:1 DCM/MeOH or trituration with DCM/hexanes), 68–76%.
Scheme 70
Scheme 70
Synthesis of (S)-(−)-2-(fluorodiphenylmethyl)pyrrolidine 107. Reagents and conditions: (a) SOCl2, MeOH, reflux, 2 h; (b) BnBr, diisopropylethylamine, toluene, reflux, 24 h, 97% overall yield; (c) PhBr, Mg, THF, rt, 16 h, 93%; (d) H2 (1 atm), HCl (aq), Pd/C, EtOH, rt, 18 h, 96%; (e) diethylaminosulfur trifluoride, DCM, rt, 6.5 h, 54%.
Scheme 71
Scheme 71
Synthesis of fluorinated aminal-pyrrolidine organocatalysts 108a,b. Reagents and conditions: (a) SOCl2, MeOH, 97%; (b) diethylaminosulfur trifluoride, DCM, −78 °C, 7 h, rt, 14 h, 74%; (c) (i) DIBAL-H, toluene, −78 °C, 6 h; (ii) diamine, DCM, MS (4 Å); (d) H2 (1 atm), Pd/C, AcOEt, 57–61%, over two steps.
Scheme 72
Scheme 72
Synthesis of densely substituted pyrrolidines 109. Reagents and conditions: (a) trans-β-nitrostyrene, sarcosine methyl ester hydrochloride, Et3N, MgSO4, toluene, reflux, 7 h, 56%; (b) glycine methyl ester hydrochloride, Et3N, MgSO4, DCM, rt, 20 h, 92%; (c) trans-β-nitrostyrene, Et3N, LiBr, THF, rt, 3 h, 66%.
Scheme 73
Scheme 73
Synthesis of bicyclic diarylprolinol silyl ethers 110a–d. Reagents and conditions: (a) Ph3P, DEAD, THF, rt, 5 h; 67%. (b) ArMgBr, THF, rt, 2–8 h; 51–85%. (c) R2SiCl2, imidazole, DMF, rt, 18 h; 63–70%. (d) H2 (1 atm), Pd/C, THF:MeOH (1:1), rt, 18–36 h; 55–85%.
Scheme 74
Scheme 74
Synthesis of bifunctional pyrrolidine-thioureas 111a–d. Reagents and conditions: (a) pyridine–SO3, DIEA, DMSO, DCM, 0 °C, 82%; (b) PhMgBr, THF, −78 °C, 58% (98:2 dr); (c) PPh3, DEAD, DPPA, THF, rt, 80%; (d) HCl (4 M), Et2O, rt, 85%; (e) a: EtBr, K2CO3, DMF, rt, 77%; b: BnBr, K2CO3, DMF, rt, 80%; c: HCOOH, HCHO, H2O, 100 °C, 62%; (f) LiAlH4, THF, rt; (g) 1-isothiocyanato-3,5-bis(trifluoromethyl)benzene, DCM, rt, 56–70%, over two steps. (h) (i) HCOOH, HCHO, H2O, 100 °C; (ii) LiAlH4, THF, rt; (iii) 1-isothiocyanato-3,5-bis(trifluoromethyl)benzene, DCM, rt, 45% overall yield.
Scheme 75
Scheme 75
Synthesis of spiro-pyrrolidines 112a,b. Reagents and conditions: (a) MsCl, Et3N, DCM, 0 °C, 5 min; (b) (R)-phenethylamine, CH3CN, 85 °C, 8 h, 87% over two steps; (c) Au(PPh3)Cl (0.5 mol%)/AgOTf (1 mol%), PTS, MS (4Å), DCM, reflux, 2 h, 43%; (d) H2 (1 atm), Pd(OH)2/C, MeOH, rt, 10 h; (e) Et3N, Boc2O, DCM, 0 °C to rt, 1 h; 95% over two steps; (f) NaBH4, MeOH, 10 min; (g) TFA, DCM, rt, 3 h; (h) imidazole, TBSCl or TBDPSCl, DMF, rt, 30 min; 83% over three steps.
Scheme 76
Scheme 76
Synthesis of fluorinated pyrrolidine 113. Reagents and conditions: (a) AcCl, MeOH, reflux, 6 h; (b) BnCl, Et3N, DCM, reflux, 6 h, 41% over two steps; (c) trichloroisocyanuric acid, TEMPO, DCM, 0 °C, 1 h, 96%; (d) diethylaminosulfur trifluoride (DAST), DCM, 0 °C to rt, 18 h, 72%; (e) 1-bromo-3,5-bis-(trifluoromethyl)-benzene, Mg, THF, 0 °C to rt, 15 h, 96%; (f) H2 (1 atm), Pd/C, EtOH/AcOEt (1:1), rt, 26 h, 94%; (g) (i) NaH, THF, 0 °C; (ii) chloro-(2,3-dimethylbutan-2-yl)dimethylsilane, rt, 5 h, 94%.
Scheme 77
Scheme 77
Synthesis of diphenylprolinol methyl ether 114. Reagents and conditions: (a) DIBAL-H, DCM, −65 °C, 30 min, 96%; (b) (S)-2-methylpropane-2-sulfinamide, Ti(OiPr)4, THF, rt, 12 h, 70%; (c) BF3∙Et2O (5 mol%), MeOH, reflux, 7 h, 91%; (d) (i) BuLi, TMEDA, THF, −40 °C, 30 min; (ii) sulfinimine, −78 °C, 1 h, 79%; (e) HCl/MeOH, 0 °C to rt, 4 h, 99%.
Scheme 78
Scheme 78
Synthesis of spiro-pyrrolidine 115. Reagents and conditions: (a) NH2OH∙HCl, NaOAc, MeOH, reflux, 4 h; (b) NiCl2, NaBH4, MeOH, −15 °C, 2 h, rt, 12 h; (c) Tf2O, Et3N, DCM, −78 °C, 30 min; (d) TFA, DCM, 0 °C, 1.5 h, 68% over four steps.

Similar articles

Cited by

References

    1. Li Petri G., Raimondi M.V., Spanò V., Holl R., Barraja P., Montalbano A. Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds. Top. Curr. Chem. 2021;379:34. doi: 10.1007/s41061-021-00347-5. - DOI - PMC - PubMed
    1. Stocker B.L., Dangerfield E.M., Win-Mason A.L., Haslett G.W., Timmer M.S.M. Recent Developments in the Synthesis of Pyrrolidine-Containing Iminosugars. Eur. J. Org. Chem. 2010;2010:1615–1637. doi: 10.1002/ejoc.200901320. - DOI
    1. Martineau D., Beley M., Gros P.C. Pyrrolidine-Containing Polypyridines: New Ligands for Improved Visible Light Absorption by Ruthenium Complexes. J. Org. Chem. 2006;71:566–571. doi: 10.1021/jo051994k. - DOI - PubMed
    1. Zhou M., El-Sayed E.S.M., Ju Z., Wang W., Yuan D. The Synthesis and Applications of Chiral Pyrrolidine Functionalized Metal-Organic Frameworks and Covalent-Organic Frameworks. Inorg. Chem. Front. 2020;7:1319–1333. doi: 10.1039/C9QI01103J. - DOI
    1. Vega-Peñaloza A., Paria S., Bonchio M., Dell’Amico L., Companyó X. Profiling the Privileges of Pyrrolidine-Based Catalysts in Asymmetric Synthesis: From Polar to Light-Driven Radical Chemistry. ACS Catal. 2019;9:6058–6072. doi: 10.1021/acscatal.9b01556. - DOI

LinkOut - more resources